The resin’s linker is designed so that cleavage leaves the assembled peptide with a C-terminal amide rather than a free carboxylic acid. This outcome is established by the attachment chemistry before the synthesis begins. Selecting this support is therefore important when the target sequence requires amidation, a structural feature found in many biologically active peptide molecules.
Each cycle exposes the next reactive site by base-mediated Fmoc removal, then extends the resin-bound chain through amino acid coupling. Repeating these two operations in sequence builds the peptide from its programmed amino acid order while the growing product remains attached to the polymer. This iterative format supports controlled assembly of defined peptide sequences.
Acidic cleavage, typically using trifluoroacetic acid, separates the completed peptide from the polymer-supported linker and produces the intended amidated terminus. It converts the protected, resin-bound intermediate into a released peptide suitable for subsequent handling. Because cleavage occurs after sequence assembly, the final product can be collected independently of the solid support.
The polymer keeps the growing peptide in a separable solid phase while soluble reagents participate in deprotection and coupling. After each operation, filtration can remove the liquid-phase materials without requiring the peptide to be isolated from solution. This handling advantage makes repeated reaction cycles more practical and contributes to compatibility with automated synthesis workflows.
A typical workflow begins by attaching or retaining the starting residue on the resin, followed by repeated base-mediated Fmoc removal and amino acid coupling. Once the desired sequence is complete, acidic treatment releases the peptide from the support. The resulting amidated product can then be handled as a discrete material for research or characterization.
This resin is useful when investigators need peptides bearing a C-terminal amide, including research standards, peptide libraries, and candidate therapeutics. Its compatibility with iterative assembly and filtration supports preparation of multiple sequences and repeated experiments. In chemical biology and medicinal chemistry, that combination helps connect peptide structure with biological or molecular research questions.